Classifications of N2 non-small-cell lung cancer based on the number and rate of metastatic mediastinal lymph nodes

Clinical Lung Cancer

Volumn 14, Issue 6, 2013, Pages 651-657

  Ito, Masaoki ^a,b   Yamashita, Yoshinori ^a   Tsutani, Yasuhiro ^b   Misumi, Keizo ^b   Harada, Hiroaki ^a   Miyata, Yoshihiro ^b   Okada, Morihito ^b  

^a NATIONAL HOSPITAL ORGANIZATION   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Lymph node; N2 disease; Non small cell lung cancer; Prognosis; Tumor staging

Indexed keywords

ADULT; ARTICLE; CANCER CLASSIFICATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; SURVIVAL RATE;

LYMPH NODE; N2 DISEASE; NON-SMALL-CELL LUNG CANCER; PROGNOSIS; TUMOR STAGING;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MEDIASTINUM; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84887245256     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2013.04.012     Document Type: Article

References (31)

1. V.W. Rusch, J. Crowley, and D.J. Giroux The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer J Thorac Oncol 2 2007 603 612
2. H. Asamura, H. Nakayama, and H. Kondo Lobe-specific extent of systematic lymph node dissection for non-small cell lung carcinomas according to a retrospective study of metastasis and prognosis J Thorac Cardiovasc Surg 117 1999 1102 1111
3. T. Naruke, R. Tsuchiya, and H. Kondo Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience Ann Thorac Surg 71 2001 1759 1764
4. L. Xie, A.M. Ugnat, and J. Morriss Histology-related variation in the treatment and survival of patients with lung carcinoma in Canada Lung Cancer 42 2003 127 139
5. V.W. Rusch, H. Asamura, and H. Watanabe The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer J Thorac Oncol 4 2009 568 577
6. S. Wei, H. Asamura, and R. Kawachi Which is the better prognostic factor for resected non-small cell lung cancer: the number of metastatic lymph nodes or the currently used nodal stage classification? J Thorac Oncol 6 2011 310 318
7. T. Fukui, S. Mori, and K. Yokoi Significance of the number of positive lymph nodes in resected non-small cell lung cancer J Thorac Oncol 1 2006 120 125
8. E. Bria, M. Milella, and I. Sperduti A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer Lung Cancer 66 2009 365 371
9. S. Jonnalagadda, C. Smith, and G. Mhango The number of lymph node metastases as a prognostic factor in patients with N1 non-small cell lung cancer Chest 140 2011 433 440
10. H. Saji, M. Tsuboi, and K. Yoshida Prognostic impact of number of resected and involved lymph nodes at complete resection on survival in non-small cell lung cancer J Thorac Oncol 6 2011 1865 1871
11. J.P. Wisnivesky, J. Arciniega, and G. Mhango Lymph node rate as a prognostic factor in elderly patients with pathological N1 non-small cell lung cancer Thorax 66 2011 287 293
12. J.P. van Meerbeeck, G.W. Kramer, and P.E. Van Schil Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer J Natl Cancer Inst 99 2007 442 450
13. K.S. Albain, R.S. Swann, and V.W. Rusch Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial Lancet 374 2009 379 386
14. D.W. Johnstone, R.W. Byhardt, and D. Ettinger Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Radiation Therapy Oncology Group Int J Radiat Oncol Biol Phys 54 2002 365 369
15. D.C. Betticher, S.F. Hsu Schmitz, and M. Tötsch Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study Br J Cancer 94 2006 1099 1106
16. J.R. Sonett, M. Suntharalingam, and M.J. Edelman Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer Ann Thorac Surg 78 2004 1200 1205
17. N. Pourel, N. Santelmo, and N. Naafa Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response Eur J Cardiothorac Surg 33 2008 829 836
18. R. Rami-Porta, D. Ball, and J. Crowley The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer J Thorac Oncol 2 2007 593 602
19. J.G. Lee, C.Y. Lee, and M.K. Bae Validity of International Association for the Study of Lung Cancer proposals for the revision of N descriptors in lung cancer J Thorac Oncol 3 2008 1421 1426
20. E. Ruffini, P.L. Filosso, and M.C. Bruna Recommended changes for T and N descriptors proposed by the International Association for the Study of Lung Cancer - Lung Cancer Staging Project: a validation study from a single-centre experience Eur J Cardiothorac Surg 36 2009 1037 1044
21. R. Rami-Porta, J.J. Crowley, and P. Goldstraw The revised TNM staging system for lung cancer Ann Thorac Cardiovasc Surg 15 2009 4 9
22. O. Birim, A.P. Kappetein, and T. Stijnen Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer Ann Thorac Surg 79 2005 375 382
23. M. Sanli, A.F. Isik, and S. Zincirkeser Reliability of positron emission tomography-computed tomography in identification of mediastinal lymph node status in patients with non-small cell lung cancer J Thorac Cardiovasc Surg 138 2009 1200 1205
24. Y.L. Lv, D.M. Yuan, and K. Wang Diagnostic performance of integrated positron emission tomography/computed tomography for mediastinal lymph node staging in non-small cell lung cancer: a bivariate systematic review and meta-analysis J Thorac Oncol 6 2011 1350 1358
25. P. De Leyn, D. Lardinois, and P.E. Van Schil ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer Eur J Cardiothorac Surg 32 2007 1 8
26. M.B. Wallace, J.M. Pascual, and M. Raimondo Minimally invasive endoscopic staging of suspected lung cancer JAMA 299 2008 540 546
27. R. Ohnishi, I. Yasuda, and T. Kato Combined endobronchial and endoscopic ultrasound-guided fine needle aspiration for mediastinal nodal staging of lung cancer Endoscopy 43 2011 1082 1089
28. J. Kuzdzał, M. Zieliński, and B. Papla Transcervical extended mediastinal lymphadenectomy: the new operative technique and early results in lung cancer staging Eur J Cardiothorac Surg 27 2005 384 390
29. M. Zieliński Transcervical extended mediastinal lymphadenectomy: results of staging in two hundred fifty-six patients with non-small cell lung cancer J Thorac Oncol 2 2007 370 372
30. S. Call, R. Rami-Porta, and M. Serra-Mitjans Extended cervical mediastinoscopy in the staging of bronchogenic carcinoma of the left lung Eur J Cardiothorac Surg 34 2008 1081 1084
31. R.J. Ginsberg Extended cervical mediastinoscopy Chest Surg Clin N Am 6 1996 21 30